Your Search for 'Worldwide Prescription Drug Market for Womens Health: Now and Future 2004-2009' returned 2 results - Page 1 of 1

• Prescription Drugs - Global Strategic Business Report

  EURO€ 3,496.00USD$ 3,950.00GBP£ 2,330.00AUD$ 5,462.00JPY¥ 473,679.00SEK 31 073,00CHF 5'202.00CAD$ 5,066.00 Global Industry Analysts, Inc, Jul 2009 , Pages: 1810
  Statins Lead the Way II-16 Emerging Leaders II-16 Table 7: Leading Cholesterol Reducing Drugs Worldwide: Sales for the years 2004 through 2008 for Lipitor, Crestor and Vytorin (in US$ Billion) (includes ...

• Condoms - Global Strategic Business Report

  EURO€ 4,381.00USD$ 4,950.00GBP£ 2,920.00AUD$ 6,845.00JPY¥ 593,598.00SEK 38 940,00CHF 6'519.00CAD$ 6,349.00 Global Industry Analysts, Inc, Oct 2012 , Pages: 271
  gaining acceptance and have completely redefined women’s empowerment. A promising and innovative health technology, the female condom is set to strengthen its market presence and play an increasing role in ...